FUJIFILM Biotechnologies has officially opened its commercial‑scale cell culture manufacturing facility in Holly Springs, North Carolina. The first phase of the $3.2 billion site brings eight 20,000‑liter mammalian cell culture bioreactors online, with plans to expand to sixteen reactors by 2026. The post New $3.2B FUJIFILM facility signals shift in biotech manufacturing power to the US appeared first on Manufacturing Today.
